Metabotropic purinergic receptors in lipid membrane microdomains

Current Medicinal Chemistry

Volumn 20, Issue 1, 2013, Pages 56-63

  D'Ambrosi, N ^a   Volonte C ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b CNR   (Italy)

Author keywords

Adenosine, caveolae; Extracellular ATP; GPCR; Lipid rafts; Membrane microdomains; Purinergic receptors

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO 6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CAVEOLIN 1; CAVEOLIN 3; CLOPIDOGREL; DOPAMINE 2 RECEPTOR; FLOTILLIN 1; G PROTEIN COUPLED RECEPTOR; PRASUGREL; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y13 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; PURINERGIC RECEPTOR;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTHMA; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CAVEOLA; CEREBROVASCULAR ACCIDENT; CYSTIC FIBROSIS; DRY EYE; ENDOCYTOSIS; HUMAN; LIPID MEMBRANE; LIPID RAFT; MOLECULAR INTERACTION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; THROMBOCYTE AGGREGATION; THROMBOSIS;

ADENOSINE; ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; ANIMALS; HUMANS; MEMBRANE MICRODOMAINS; MOLECULAR SEQUENCE DATA; RECEPTORS, PURINERGIC;

EID: 84872969922     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673130107     Document Type: Article

References (82)

1. Fredholm, B.B.; AP, I.J.; Jacobson, K.A.; Linden, J.; Muller, C.E., International Union of Basic and Clinical Pharmacology. LXXX.I. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev, 2011, 63, (1), 1-34.
2. Harden, T.K.; Sesma, J.I.; Fricks, I.P.; Lazarowski, E.R., Signalling and pharmacological properties of the P2Y receptor. Acta Physiol (Oxf), 2010, 199, (2), 149-160.
3. Browne, L.E.; Jiang, L.H.; North, R.A., New structure enlivens interest in P2X receptors. Trends Pharmacol Sci, 2010, 31, (5), 229-237.
4. Burnstock, G., Discovery of Purinergic Signalling, the Initial Resistance and Current Explosion of Interest. Br J Pharmacol, 2012.
5. Bjarnadottir, T.K.; Gloriam, D.E.; Hellstrand, S.H.; Kristiansson, H.; Fredriksson, R.; Schioth, H.B., Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics, 2006, 88, (3), 263-273.
6. Fredholm, B.B.; AP, I.J.; Jacobson, K.A.; Klotz, K.N.; Linden, J., International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev, 2001, 53, (4), 527-552.
7. Jacobson, K.A.; Balasubramanian, R.; Deflorian, F.; Gao, Z.G., G proteincoupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions. Purinergic Signal, 2012.
8. Muller, C.E.; Jacobson, K.A., Recent developments in adenosine receptor ligands and their potential as novel drugs. Biochim Biophys Acta, 2011, 1808, (5), 1290-1308.
9. Hasko, G.; Linden, J.; Cronstein, B.; Pacher, P., Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov, 2008, 7, (9), 759-770.
10. Jacobson, K.A., Introduction to adenosine receptors as therapeutic targets. Handb Exp Pharmacol, 2009, (193), 1-24.
11. Lopes, L.V.; Sebastiao, A.M.; Ribeiro, J.A., Adenosine and related drugs in brain diseases: present and future in clinical trials. Curr Top Med Chem, 2011, 11, (8), 1087-1101.
12. Abbracchio, M.P.; Burnstock, G.; Boeynaems, J.M.; Barnard, E.A.; Boyer, J.L.; Kennedy, C.; Knight, G.E.; Fumagalli, M.; Gachet, C.; Jacobson, K.A.; Weisman, G.A., International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev, 2006, 58, (3), 281-341.
13. Jacobson, K.A.; Boeynaems, J.M., P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov Today, 2010, 15, (13-14), 570-578.
14. Volonté, C.; Amadio, S.; D'Ambrosi, N.; Colpi, M.; Burnstock, G., P2 receptor web: complexity and fine-tuning. Pharmacol Ther, 2006, 112, (1), 264-280.
15. Volonté, C.; Amadio, S.; D'Ambrosi, N., Receptor webs: can the chunking theory tell us more about it? Brain Res Rev, 2008, 59, (1), 1-8.
16. Volonté, C.; D'Ambrosi, N.; Amadio, S., Protein cooperation: from neurons to networks. Prog Neurobiol, 2008, 86, (2), 61-71.
17. Schicker, K.; Hussl, S.; Chandaka, G.K.; Kosenburger, K.; Yang, J.W.; Waldhoer, M.; Sitte, H.H.; Boehm, S., A membrane network of receptors and enzymes for adenine nucleotides and nucleosides. Biochim Biophys Acta, 2009, 1793, (2), 325-334.
18. Escudero, C.; Casanello, P.; Sobrevia, L., Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia. Placenta, 2008, 29, (9), 816-825.
19. Jiang, L.; Bardini, M.; Keogh, A.; dos Remedios, C.G.; Burnstock, G., P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium. Int J Cardiol, 2005, 98, (2), 291-297.
20. D'Ambrosi, N.; Iafrate, M.; Vacca, F.; Amadio, S.; Tozzi, A.; Mercuri, N.B.; Volonté, C., The P2Y receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells. Purinergic Signal, 2006, 2, (4), 575-582.
21. Koles, L.; Gerevich, Z.; Oliveira, J.F.; Zadori, Z.S.; Wirkner, K.; Illes, P., Interaction of P2 purinergic receptors with cellular macromolecules. Naunyn Schmiedebergs Arch Pharmacol, 2008, 377, (1), 1-33.
22. Rumjahn, S.M.; Yokdang, N.; Baldwin, K.A.; Thai, J.; Buxton, I.L., Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis. Br J Cancer, 2009, 100, (9), 1465-1470.
23. Buvinic, S.; Bravo-Zehnder, M.; Boyer, J.L.; Huidobro-Toro, J.P.; Gonzalez, A., Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells. J Cell Sci, 2007, 120, (Pt 24), 4289-4301.
24. Norambuena, A.; Poblete, M.I.; Donoso, M.V.; Espinoza, C.S.; Gonzalez, A.; Huidobro-Toro, J.P., P2Y1 receptor activation elicits its partition out of membrane rafts and its rapid internalization from human blood vessels: implications for receptor signaling. Mol Pharmacol, 2008, 74, (6), 1666-1677.
25. Assaife-Lopes, N.; Sousa, V.C.; Pereira, D.B.; Ribeiro, J.A.; Chao, M.V.; Sebastiao, A.M., Activation of adenosine A2A receptors induces TrkB translocation and increases BDNF-mediated phospho-TrkB localization in lipid rafts: implications for neuromodulation. J Neurosci, 2010, 30, (25), 8468-8480.
26. Kim, H.J.; Ajit, D.; Peterson, T.S.; Wang, Y.; Camden, J.M.; Gibson Wood, W.; Sun, G.Y.; Erb, L.; Petris, M.; Weisman, G.A., Nucleotides released from Abeta(1)(-)(4)(2) -treated microglial cells increase cell migration and Abeta(1)(-)(4)(2) uptake through P2Y(2) receptor activation. J Neurochem, 2012, 121, (2), 228-238.
27. Peterson, T.S.; Camden, J.M.; Wang, Y.; Seye, C.I.; Wood, W.G.; Sun, G.Y.; Erb, L.; Petris, M.J.; Weisman, G.A., P2Y2 nucleotide receptor-mediated responses in brain cells. Mol Neurobiol, 2010, 41, (2-3), 356-366.
28. Kamae, T.; Shiraga, M.; Kashiwagi, H.; Kato, H.; Tadokoro, S.; Kurata, Y.; Tomiyama, Y.; Kanakura, Y., Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation. J Thromb Haemost, 2006, 4, (6), 1379-1387.
29. Sullivan, G.W.; Lee, D.D.; Ross, W.G.; DiVietro, J.A.; Lappas, C.M.; Lawrence, M.B.; Linden, J., Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils. J Leukoc Biol, 2004, 75, (1), 127-134.
30. Volonté, C.; D'Ambrosi, N., Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters. Febs J, 2009, 276, (2), 318-329.
31. Vacca, F.; Amadio, S.; Sancesario, G.; Bernardi, G.; Volonté, C., P2X3 receptor localizes into lipid rafts in neuronal cells. J Neurosci Res, 2004, 76, (5), 653-661.
32. Garcia-Marcos, M.; Dehaye, J.P.; Marino, A., Membrane compartments and purinergic signalling: the role of plasma membrane microdomains in the modulation of P2XR-mediated signalling. Febs J, 2009, 276, (2), 330-340.
33. Kenworthy, A.K.; Edidin, M., Distribution of a glycosylphosphatidylinositolanchored protein at the apical surface of MDCK cells examined at a resolution of <100 A using imaging fluorescence resonance energy transfer. J Cell Biol, 1998, 142, (1), 69-84.
34. Delaunay, J.L.; Breton, M.; Goding, J.W.; Trugnan, G.; Maurice, M., Differential detergent resistance of the apical and basolateral NPPases: relationship with polarized targeting. J Cell Sci, 2007, 120, (Pt 6), 1009-1016.
35. Schubert, A.L.; Schubert, W.; Spray, D.C.; Lisanti, M.P., Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry, 2002, 41, (18), 5754-5764.
36. Kowalski, M.P.; Pier, G.B., Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J Immunol, 2004, 172, (1), 418-425.
37. Mundell, S.; Kelly, E., Adenosine receptor desensitization and trafficking. Biochim Biophys Acta, 2011, 1808, (5), 1319-1328.
38. Gao, Z.; Ni, Y.; Szabo, G.; Linden, J., Palmitoylation of the recombinant human A1 adenosine receptor: enhanced proteolysis of palmitoylationdeficient mutant receptors. Biochem J, 1999, 342 (Pt 2), 387-395.
39. Ferguson, G.; Watterson, K.R.; Palmer, T.M., Subtype-specific regulation of receptor internalization and recycling by the carboxyl-terminal domains of the human A1 and rat A3 adenosine receptors: consequences for agoniststimulated translocation of arrestin3. Biochemistry, 2002, 41, (50), 14748-14761.
40. Lasley, R.D., Adenosine receptors and membrane microdomains. Biochim Biophys Acta, 2011, 1808, (5), 1284-1289.
41. Shryock, J.C.; Belardinelli, L., Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol, 1997, 79, (12A), 2-10.
42. Lasley, R.D.; Narayan, P.; Uittenbogaard, A.; Smart, E.J., Activated cardiac adenosine A(1) receptors translocate out of caveolae. J Biol Chem, 2000, 275, (6), 4417-4421.
43. Yang, Z.; Sun, W.; Hu, K., Adenosine A(1) receptors selectively target protein kinase C isoforms to the caveolin-rich plasma membrane in cardiac myocytes. Biochim Biophys Acta, 2009, 1793, (12), 1868-1875.
44. Ballard-Croft, C.; Locklar, A.C.; Keith, B.J.; Mentzer, R.M., Jr.; Lasley, R.D., Oxidative stress and adenosine A1 receptor activation differentially modulate subcellular cardiomyocyte MAPKs. Am J Physiol Heart Circ Physiol, 2008, 294, (1), H263-271.
45. Garg, V.; Jiao, J.; Hu, K., Regulation of ATP-sensitive K+ channels by caveolin-enriched microdomains in cardiac myocytes. Cardiovasc Res, 2009, 82, (1), 51-58.
46. Schwarzer, S.; Nobles, M.; Tinker, A., Do caveolae have a role in the fidelity and dynamics of receptor activation of G-protein-gated inwardly rectifying potassium channels? J Biol Chem, 2010, 285, (36), 27817-27826.
47. Gines, S.; Ciruela, F.; Burgueno, J.; Casado, V.; Canela, E.I.; Mallol, J.; Lluis, C.; Franco, R., Involvement of caveolin in ligand-induced recruitment and internalization of A(1) adenosine receptor and adenosine deaminase in an epithelial cell line. Mol Pharmacol, 2001, 59, (5), 1314-1323.
48. Escriche, M.; Burgueno, J.; Ciruela, F.; Canela, E.I.; Mallol, J.; Enrich, C.; Lluis, C.; Franco, R., Ligand-induced caveolae-mediated internalization of A1 adenosine receptors: morphological evidence of endosomal sorting and receptor recycling. Exp Cell Res, 2003, 285, (1), 72-90.
49. Murthy, K.S.; Makhlouf, G.M., Heterologous desensitization mediated by G protein-specific binding to caveolin. J Biol Chem, 2000, 275, (39), 30211-30219.
50. Ostrom, R.S.; Insel, P.A., The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol, 2004, 143, (2), 235-245.
51. Mojsilovic-Petrovic, J.; Jeong, G.B.; Crocker, A.; Arneja, A.; David, S.; Russell, D.S.; Kalb, R.G., Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. J Neurosci, 2006, 26, (36), 9250-9263.
52. Sebastiao, A.M.; Assaife-Lopes, N.; Diogenes, M.J.; Vaz, S.H.; Ribeiro, J.A., Modulation of brain-derived neurotrophic factor (BDNF) actions in the nervous system by adenosine A(2A) receptors and the role of lipid rafts. Biochim Biophys Acta, 2011, 1808, (5), 1340-1349.
53. Genedani, S.; Guidolin, D.; Leo, G.; Filaferro, M.; Torvinen, M.; Woods, A.S.; Fuxe, K.; Ferre, S.; Agnati, L.F., Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2Adopamine D2 receptor heterodimers. J Mol Neurosci, 2005, 26, (2-3), 177-184.
54. Charalambous, C.; Gsandtner, I.; Keuerleber, S.; Milan-Lobo, L.; Kudlacek, O.; Freissmuth, M.; Zezula, J., Restricted collision coupling of the A2A receptor revisited: evidence for physical separation of two signaling cascades. J Biol Chem, 2008, 283, (14), 9276-9288.
55. Lyman, E.; Higgs, C.; Kim, B.; Lupyan, D.; Shelley, J.C.; Farid, R.; Voth, G.A., A role for a specific cholesterol interaction in stabilizing the Apo configuration of the human A(2A) adenosine receptor. Structure, 2009, 17, (12), 1660-1668.
56. Zezula, J.; Freissmuth, M., The A(2A)-adenosine receptor: a GPCR with unique features? Br J Pharmacol, 2008, 153 Suppl 1, S184-190.
57. Lam, R.S.; Nahirney, D.; Duszyk, M., Cholesterol-dependent regulation of adenosine A(2A) receptor-mediated anion secretion in colon epithelial cells. Exp Cell Res, 2009, 315, (17), 3028-3035.
58. Kamata, K.; Manno, S.; Ozaki, M.; Takakuwa, Y., Functional evidence for presence of lipid rafts in erythrocyte membranes: Gsalpha in rafts is essential for signal transduction. Am J Hematol, 2008, 83, (5), 371-375.
59. Sitaraman, S.V.; Wang, L.; Wong, M.; Bruewer, M.; Hobert, M.; Yun, C.H.; Merlin, D.; Madara, J.L., The adenosine 2b receptor is recruited to the plasma membrane and associates with E3KARP and Ezrin upon agonist stimulation. J Biol Chem, 2002, 277, (36), 33188-33195.
60. Cordeaux, Y.; Briddon, S.J.; Alexander, S.P.; Kellam, B.; Hill, S.J., Agonistoccupied A3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells. Faseb J, 2008, 22, (3), 850-860.
61. Costanzi, S.; Mamedova, L.; Gao, Z.G.; Jacobson, K.A., Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J Med Chem, 2004, 47, (22), 5393-5404.
62. Burnstock, G., Dual control of local blood flow by purines. Ann N Y Acad Sci, 1990, 603, 31-44; discussion 44-35.
63. Burnstock, G., Control of vascular tone by purines and pyrimidines. Br J Pharmacol, 2010, 161, (3), 527-529.
64. Kaiser, R.A.; Oxhorn, B.C.; Andrews, G.; Buxton, I.L., Functional compartmentation of endothelial P2Y receptor signaling. Circ Res, 2002, 91, (4), 292-299.
65. Uehara, K.; Uehara, A., P2Y1, P2Y6, and P2Y12 receptors in rat splenic sinus endothelial cells: an immunohistochemical and ultrastructural study. Histochem Cell Biol, 2011, 136, (5), 557-567.
66. Kittel, A.; Csapo, Z.S.; Csizmadia, E.; Jackson, S.W.; Robson, S.C., Colocalization of P2Y1 receptor and NTPDase1/CD39 within caveolae in human placenta. Eur J Histochem, 2004, 48, (3), 253-259.
67. Weerth, S.H.; Holtzclaw, L.A.; Russell, J.T., Signaling proteins in raft-like microdomains are essential for Ca2+ wave propagation in glial cells. Cell Calcium, 2007, 41, (2), 155-167.
68. Amadio, S.; Vacca, F.; Martorana, A.; Sancesario, G.; Volonté, C., P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex. BMC Dev Biol, 2007, 7, 77.
69. Elliott, M.R.; Chekeni, F.B.; Trampont, P.C.; Lazarowski, E.R.; Kadl, A.; Walk, S.F.; Park, D.; Woodson, R.I.; Ostankovich, M.; Sharma, P.; Lysiak, J.J.; Harden, T.K.; Leitinger, N.; Ravichandran, K.S., Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature, 2009, 461, (7261), 282-286.
70. Weisman, G.A.; Ajit, D.; Garrad, R.; Peterson, T.S.; Woods, L.T.; Thebeau, C.; Camden, J.M.; Erb, L., Neuroprotective roles of the P2Y(2) receptor. Purinergic Signal, 2012.
71. Ando, K.; Obara, Y.; Sugama, J.; Kotani, A.; Koike, N.; Ohkubo, S.; Nakahata, N., P2Y2 receptor-Gq/11 signaling at lipid rafts is required for UTPinduced cell migration in NG 108-15 cells. J Pharmacol Exp Ther, 2010, 334, (3), 809-819.
72. Sugama, J.; Ohkubo, S.; Atsumi, M.; Nakahata, N., Mastoparan changes the cellular localization of Galphaq/11 and Gbeta through its binding to ganglioside in lipid rafts. Mol Pharmacol, 2005, 68, (5), 1466-1474.
73. Sugawara, Y.; Nishii, H.; Takahashi, T.; Yamauchi, J.; Mizuno, N.; Tago, K.; Itoh, H., The lipid raft proteins flotillins/reggies interact with Galphaq and are involved in Gq-mediated p38 mitogen-activated protein kinase activation through tyrosine kinase. Cell Signal, 2007, 19, (6), 1301-1308.
74. Bhatnagar, A.; Sheffler, D.J.; Kroeze, W.K.; Compton-Toth, B.; Roth, B.L., Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors. J Biol Chem, 2004, 279, (33), 34614-34623.
75. Flores, R.V.; Hernandez-Perez, M.G.; Aquino, E.; Garrad, R.C.; Weisman, G.A.; Gonzalez, F.A., Agonist-induced phosphorylation and desensitization of the P2Y2 nucleotide receptor. Mol Cell Biochem, 2005, 280, (1-2), 35-45.
76. D'Ambrosi, N.; Iafrate, M.; Saba, E.; Rosa, P.; Volonté, C., Comparative analysis of P2Y4 and P2Y6 receptor architecture in native and transfected neuronal systems. Biochim Biophys Acta, 2007, 1768, (6), 1592-1599.
77. Bhatt, D.L.; Topol, E.J., Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov, 2003, 2, (1), 15-28.
78. Gachet, C., Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol, 2006, 46, 277-300.
79. von Kugelgen, I.; Harden, T.K., Molecular pharmacology, physiology, and structure of the P2Y receptors. Adv Pharmacol, 2011, 61, 373-415.
80. Quinton, T.M.; Kim, S.; Jin, J.; Kunapuli, S.P., Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADPmediated platelet activation. J Thromb Haemost, 2005, 3, (5), 1036-1041.
81. Vial, C.; Fung, C.Y.; Goodall, A.H.; Mahaut-Smith, M.P.; Evans, R.J., Differential sensitivity of human platelet P2X1 and P2Y1 receptors to disruption of lipid rafts. Biochem Biophys Res Commun, 2006, 343, (2), 415-419.
82. Savi, P.; Zachayus, J.L.; Delesque-Touchard, N.; Labouret, C.; Herve, C.; Uzabiaga, M.F.; Pereillo, J.M.; Culouscou, J.M.; Bono, F.; Ferrara, P.; Herbert, J.M., The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Proc Natl Acad Sci U S A, 2006, 103, (29), 11069-11074.